The concept of GvHD-suppression by in vitro treatment with antisera.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000912:Antibodies, Neoplasm / Q000008:administration & dosage / Q000276:immunology; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001853:Bone Marrow / Q000276:immunology; D016026:Bone Marrow Transplantation; D002678:Chimera; D004285:Dogs; D006087:Graft vs Host Reaction; D006801:Humans; D007108:Immune Tolerance; D007938:Leukemia / Q000628:therapy*; D008722:Methods; D051379:Mice; D008810:Mice, Inbred C57BL; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000961:Antilymphocyte Serum